POST Online Media Lite Edition


Eton Pharmaceuticals appoints Paul V. Maier to board

Staff Writer |
Deer Park, Ill., USA - September 15, 2017, Deer Park, Ill., USA - Eton Pharmaceuticals, a development stage pharmaceutical company, announced it has appointed Paul V. Maier to its board of directors.

Article continues below

Mr. Maier currently serves as a financial advisor to the life science industry.

Mr. Maier is the former CFO of Sequenom, Inc. and Ligand Pharmaceuticals Inc. and has over 25 years experience as a senior executive in biotechnology and specialty pharmaceutical companies.

Mr. Maier has served on the boards of eight companies and currently serves as Audit Committee Chair on four public life science companies.

He received an M.B.A from Harvard Business School and a B.S. from Pennsylvania State University.


What to read next

Apricus Bio appoints Paul V. Maier to the board
Eton Pharmaceuticals appoints Sean Brynjelsen as CEO
Paul Maier joins NACR and S1 IT as SVP, president